2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
| 热门AI工具: |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Pharmacogenomics & Personalized Medicine PHARMACOGEN PERS MED (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.9
52人评分
我要评分
声誉 7.1 影响力 4.7 速度 7.1 | |||||||||||||||||||||
| 期刊ISSN | 1178-7066 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日:1.954 | |||||||||||||||||||||
| 2025-2026自引率 | 0.0%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 2.197数据由网友[velvetexplorer394]收集提供 | |||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journal | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Comparative Analysis of SLCO1B1 Gene Polymorphisms in Dyslipidemic and Normolipidemic Patients with Type 2 Diabetes Mellitus Residing at High Altitude Author: Ma, Yong-Hong; Ji, Zong-Hong; Han, Chun-Na; Ma, Sheng-Hua; Ma, Jin-Lan; Zhang, Rui-Xia; Ni-Yang, Zhuo-Ma; Zhao, Zhi-Xi; Zhang, Qi-Fu Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S593658 Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review Author: Xu, Panfeng; Lu, Shan Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S591506 Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies Author: Wang, Xu; Yang, Ping; Rao, Feng; Wang, Longnan; Mou, Fenglin; Zhang, Huimei; Chen, QiuYan; Yin, Zheng; Jing, Yanzi; Liu, Qiang; Xu, Xianrui; Zhang, Qing Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S621616 Association Between UGT1A9 rs13418420 Polymorphism and Propofol Induction Characteristics in Chinese Female Patients Undergoing Brief Gynecological Procedures Author: Huang, Xuanwei; Tan, Yuxin; Gu, Qingling; Zhang, Liang; Chen, Haofeng; Ruan, Xiaolin; Zhou, Xiangcheng; Wang, Zhongxing; Xue, Faling; Jia, Jie Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S611673 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Pharmacogenomics & Personalized Medicine的语言要求,还能让Pharmacogenomics & Personalized Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Pharmacogenomics & Personalized Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇) 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:genomic profiling、genetics、pharmacology、drug metabolism 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||
| 出版商 | Dove Medical Press | |||||||||||||||||||||
| 涉及的研究方向 | Biochemistry, Genetics and Molecular Biology-Molecular Medicine | |||||||||||||||||||||
| 出版国家或地区 | New Zealand | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 23点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 98.73% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 78.26% | |||||||||||||||||||||
| WOS期刊JCR分区 ( 2025-2026年最新版) | 注册或登录后,查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7066%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 16 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Pharmacogenomics & Personalized Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇) 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Comparative Analysis of SLCO1B1 Gene Polymorphisms in Dyslipidemic and Normolipidemic Patients with Type 2 Diabetes Mellitus Residing at High Altitude Author: Ma, Yong-Hong; Ji, Zong-Hong; Han, Chun-Na; Ma, Sheng-Hua; Ma, Jin-Lan; Zhang, Rui-Xia; Ni-Yang, Zhuo-Ma; Zhao, Zhi-Xi; Zhang, Qi-Fu Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S593658 PubMed DOI |
| 2. | Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review Author: Xu, Panfeng; Lu, Shan Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S591506 DOI |
| 3. | Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies Author: Wang, Xu; Yang, Ping; Rao, Feng; Wang, Longnan; Mou, Fenglin; Zhang, Huimei; Chen, QiuYan; Yin, Zheng; Jing, Yanzi; Liu, Qiang; Xu, Xianrui; Zhang, Qing Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S621616 DOI |
| 4. | Association Between UGT1A9 rs13418420 Polymorphism and Propofol Induction Characteristics in Chinese Female Patients Undergoing Brief Gynecological Procedures Author: Huang, Xuanwei; Tan, Yuxin; Gu, Qingling; Zhang, Liang; Chen, Haofeng; Ruan, Xiaolin; Zhou, Xiangcheng; Wang, Zhongxing; Xue, Faling; Jia, Jie Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S611673 DOI |
| 5. | Molecular Epidemiology of Thalassemia in University Town, Chongqing: Spectrum of Pathogenic Variants and Implications for Carrier Screening Author: Cai, Wei; Liang, Yi; Kang, Li-Na; Jin, Ya-Qian; Xu, Pan Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S608098 PubMed DOI |
| 6. | Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches Author: Lu, Zhenhuan; Li, Xiaowen; Liang, Zhiping; Zhang, Xiaocong; Tan, Yiyan; Kuang, Yinglan; Li, Kang; Zhu, Xiaofeng Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S566928 PubMed DOI |
| 7. | Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report Author: Xu, Ruoxiang; Zhang, Mingrui; Zeng, Zhiming; Wei, Yongguang; Liao, Xiwen; Yang, Chengkun; Peng, Tao; Su, Hao Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S578577 PubMed DOI |
| 8. | Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review Author: Xie, Zhuohua; Deng, Yanting; Zhang, Xinru; Chen, Jieyi; Deng, Jiasheng; Fang, Yibin; Ye, Xiaoxue; Zhou, Zhipin Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S555701 DOI |
| 9. | Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study Author: Han, Ruixue; Yu, Xin Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S566952 DOI |
| 10. | Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma Author: Li, Shouying; Zhang, Chunfang; Lv, Shengxiang; Zhang, Zhimei; Xu, Dazhou; Xu, Tonglei Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S562602 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共2条 |
||||||||||||||||
|
|

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室